Live Breaking News & Updates on ரட்ஜர்ஸ் புற்றுநோய் நிறுவனம் ஆஃப் புதியது ஜெர்சி

Stay updated with breaking news from ரட்ஜர்ஸ் புற்றுநோய் நிறுவனம் ஆஃப் புதியது ஜெர்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Studies find combination chemotherapy beneficial and cost-effective in sub-Saharan Africa


 E-Mail
IMAGE: UNC LIneberger s Matthew Painschab, MD, and colleagues report in Lancet Global Health that they have demonstrated in a clinical trial in Malawi that a five-drug combination chemotherapy provided curative benefit.
view more 
Credit: UNC School of Medicine
CHAPEL HILL, North Carolina Researchers at the UNC Lineberger Comprehensive Cancer Center demonstrated in a clinical trial in Malawi that a five-drug combination chemotherapy provided curative benefit compared to current standard-of care-therapy in people diagnosed with lymphoma, and now they have determined this option is also cost-effective. The economic finding appeared July 22, 2021, in
Lancet Global Health.
The clinical trial results, reported May 19, 2021, in ....

Stephen Kimani , Stephanie Wheeler , Edwards Kasonkanji , Racquele Kohler , Lineberger Matthew Painschab , Richard Nyasosela , Noel Mumba , Satish Gopal , Victor Mithi , Takondwa Zuze , Bongani Kaimila , Gillings School Of Global Public Health , School Of Medicine , National Cancer Institute , Rutgers Cancer Institute Of New Jersey , Lancet Global Health , Lineberger Comprehensive Cancer Center , Global Health , Division Of Hematology , North Carolina Researchers , Comprehensive Cancer Center , Lancet Global , Matthew Painschab , Chapel Hill , Global Public Health , Wilberforce Mhango ,